The gap in care is stark and well-documented, but it took a physician in the emergency department to see it as a business. For the millions of Americans with chronic obstructive pulmonary disease (COPD), pulmonary rehabilitation is a gold-standard therapy proven to improve quality of life and keep people out of the hospital. Yet, for a host of logistical and geographic reasons, only about 3% of eligible patients can access it [Y Combinator]. Kivo Health was founded on the premise that this 97% gap is not just a clinical failure, but a massive, addressable market for a new kind of virtual care.
Launched publicly from Y Combinator's Winter 2023 batch, Kivo provides an AI-enabled, telehealth pulmonary rehabilitation program for people with chronic lung disease, starting with COPD [Y Combinator]. Its core service is an 8-to-9-week program where patients connect with respiratory therapists over live video, a structure designed to fit into a patient's home and billed through insurance [LinkedIn, kivohealth.com]. The company's bet is that by delivering this care remotely, it can simultaneously improve patient outcomes and generate hard savings for health plans by preventing costly hospital admissions,a value proposition that has attracted a $10 million Series A and partners like Optum [Axios, October 2026].
The clinical and financial wedge
Kivo's model sits at the intersection of two powerful trends in healthcare: the expansion of reimbursable telehealth and the industry's relentless shift toward value-based care. The company sells primarily to health plans and healthcare organizations, arguing its program keeps members healthier and reduces medical spend [Roundfunded]. Its publicly cited financial metrics are ambitious: an average of over $8,000 in savings per patient and a projected 3.1x return on investment for health plans managing Medicare Advantage members [Y Combinator, kivohealth.com].
For a plan with 100,000 covered lives, Kivo projects nearly $10 million in cost savings [kivohealth.com/health-plans]. These figures, reportedly backed by actuarial analysis, form the core of its sales pitch to payers who are increasingly measured on both cost and quality outcomes [Luke Hall - Chief of Staff at Haystack Health, retrieved 2026]. The "AI-enabled" component of its service likely focuses on patient engagement, personalized care plan adjustments, and identifying those at highest risk for deterioration, though the company has not detailed its specific algorithms.
A founder duo built for the regulatory maze
The team reflects the dual challenge of building in this space: it requires deep clinical credibility and the operational rigor to scale a tech-enabled service. Co-founder and CEO Victor Sadauskas is a Stanford-trained physician who practiced emergency medicine at Kaiser Permanente and has a background in digital health investing [YesPress, TechCrunch]. This hybrid experience,seeing the acute consequences of poorly managed chronic disease while understanding the capital landscape,informs Kivo's approach.
His partner, co-founder and CTO Vaughn Koch, is a serial entrepreneur whose previous company, Movity, was part of Y Combinator's Winter 2010 batch and later exited to Trulia [Kivo Health]. The pairing follows a classic healthtech pattern: the clinician-founder defines the problem and builds trust with providers, while the technologist-founder builds the platform to deliver it reliably. They are advised by a group with significant healthcare and business credentials, including Andrew Schutzbank, MD, MPH [Schutzworks.com].
Traction through strategic partnerships
Kivo's go-to-market strategy relies on embedding its service within established healthcare systems. Its roster of partners is a key traction signal, lending credibility and providing a built-in channel for patient referrals. The company lists Stanford and UCLA as early health-system partners [Y Combinator].
A more significant, recent partnership is with Optum Arcadia, part of Optum California's medical group and physician network. The collaboration aims to combine Arcadia's value-based care infrastructure with Kivo's virtual rehab program for patients in California [streetinsider.com]. This kind of partnership is critical, as it moves Kivo beyond a standalone app and into the clinical workflow of a major player in value-based care.
| Metric | Value |
|---|---|
| Seed & Launch (2023) | 0 Public Partners |
| Partnership Phase (2024-2026) | 3 Major Health Systems |
| Value-Based Expansion (2026) | 1 Integrated Payer-Provider (Optum) |
The risks in a crowded virtual care landscape
The ambition is clear, but the path is fraught with challenges common to digital health. Kivo is not just selling software; it's selling a complex clinical service that must prove its efficacy, integrate with legacy systems, and consistently demonstrate return on investment in a noisy market.
- Clinical evidence. While pulmonary rehab itself is evidence-based, Kivo's specific telehealth delivery model and its AI components will need robust, peer-reviewed outcomes data to achieve widespread adoption beyond early partners. The company's reported ROI figures are a start, but payers and large health systems often require published studies.
- Scalability of care delivery. The model depends on a network of qualified respiratory therapists to deliver live video sessions. Recruiting, training, and retaining this clinical workforce at scale, while maintaining quality, is a significant operational hurdle distinct from pure software scaling.
- Reimbursement and competition. The telehealth reimbursement landscape remains fluid. While COVID-19 ushered in permanent changes, policy shifts could affect profitability. Furthermore, while no direct competitors are named in sources, Kivo operates in a sector where large telehealth providers and incumbent disease management companies could quickly build or buy similar capabilities.
The company's most plausible answer to these risks is its focus on a single, high-cost disease state (COPD) and its alignment with the financial incentives of value-based care partners like Optum. By proving its model in one vertical with a clear economic story, it aims to build a defensible beachhead.
The next twelve months
With its Series A capital, the immediate priorities will be scaling its clinical operations, deepening integrations with key partners like Optum, and potentially expanding its service within chronic lung disease. The open roles for a Full-Stack Engineer and a Health Systems Account Manager signal a focus on both platform robustness and sales execution [Ashbyhq, kivohealth.com/careers]. A logical milestone to watch for would be the publication of clinical or economic outcomes data from its partnerships, which would serve as a powerful validator for future health plan contracts.
For patients with moderate to severe COPD, the standard of care today is often fragmented and reactive. It can involve multiple emergency department visits for acute exacerbations, revolving-door hospital admissions, and a heavy reliance on rescue inhalers, all while the foundational, life-improving therapy of pulmonary rehab remains out of reach. Kivo Health is betting that a nine-week virtual connection can break that cycle, turning a neglected guideline recommendation into a routine, reimbursed service. The patient population, often older and less mobile, stands to gain the most from care that finally comes to them.
Sources
- [Y Combinator, February 2023] Kivo Health: AI-powered care for seniors with chronic disease | https://www.ycombinator.com/companies/kivo-health
- [Axios, October 2026] Exclusive: Kivo Health nabs $10M for lung disease | https://www.axios.com/pro/health-tech-deals/2026/10/23/kivo-health-10m-lung-disease-copd
- [Roundfunded, Unknown] Kivo Health company profile | https://www.roundfunded.com/es/yc-startup/kivo-health
- [kivohealth.com, retrieved 2026] Health Plans page and Careers page | https://kivohealth.com/health-plans, https://kivohealth.com/careers/health-systems-account-manager
- [Luke Hall - Chief of Staff at Haystack Health, retrieved 2026] LinkedIn post referencing Kivo Health ROI | https://www.linkedin.com/in/luke-hall-ba27a81a8/
- [YesPress, Unknown] Victor Sadauskas profile | https://yespress.io/victor-sadauskas
- [TechCrunch, retrieved 2026] Victor Sadauskas, Author at TechCrunch | https://techcrunch.com/author/victor-sadauskas/
- [LinkedIn, Unknown] Kivo Health company page | https://www.linkedin.com/company/kivo-health
- [streetinsider.com, retrieved 2026] Optum Arcadia and Kivo Health Launch AI-Powered, Virtual Lung Rehab | https://streetinsider.com/Business+Wire/Optum+Arcadia+and+Kivo+Health+Launch+AI-Powered,+Virtual+Lung+Rehab+and+Care+for+Patients+in+California/26303970.html
- [Ashbyhq, Unknown] Full-Stack Engineer job posting | https://jobs.ashbyhq.com/kivo-health/c48b7afe-2f4b-4821-9561-87aa4663e483
- [Schutzworks.com, retrieved 2026] Andrew Schutzbank MD, MPH | Healthcare Advisor | https://schutzworks.com/